基于随机森林算法的肿瘤科护士工作倦怠影响因素分析:一项多中心研究

目的 采用随机森林算法探讨肿瘤科护士工作倦怠的影响因素。 方法 于2018年3—8月对广西全区25所三级综合医院和专科医院1253名肿瘤科护士采用一般资料问卷、工作倦怠量表、心理资本量表进行横断面调查,分析其工作倦怠现状及其影响因素,使用随机森林分析对可能影响肿瘤科护士工作倦怠的自变量进行重要性排序,将袋外估算误差率最小的变量集纳入logistic回归模型,分析自变量的作用方向和相对危险度。 结果 逐步随机森林分析显示,变量数为8时的袋外估算误差率最低,重要性排名前8的变量依次为收入状况满意度、护患关系满意度、从事肿瘤科护理工作年限、心理资本、年龄、参加院级以上培训次数、群众认可与尊重程度、夜班频次;Logistic回归分析显示,收入状况满意度为一般（OR=1.228,95%CI:1.019~1.497）和不满意或很不满意（OR=1.276,95%CI:1.005~1.621）、护患关系满意度为一般（OR=1.158,95%CI:1.036~1.295）和不满意或很不满意组（OR=1.196,95%CI:1.020~1.402）、从事肿瘤科护理工作5~10年（OR=1.365,95%CI:1.001~1.860）和>10年（OR=1.702,95%CI:1.222~2.371）、心理资本（OR=0.904,95%CI:0.824~0.991）、年龄25~30岁（OR=1.347, 95%CI:1.010~1.797）和>30岁（OR=1.397,95%CI:1.007~1.937）、参加院级以上培训次数1~2次/年（OR=1.107,95%CI:1.008~1.217）、群众认可与尊重程度为一般（OR=1.105,95%CI:1.008~1.212）和不尊重（OR=1.260,95%CI:1.010~1.572）、夜班频次<1次/周（OR=1.115,95%CI:1.025~1.213）和≥1次/周（OR=1.397,95%CI:1.146~1.702）是肿瘤科护士工作倦怠的独立危险因素（P<0.05）。 结论 影响肿瘤科护士工作倦怠的前8位因素依次为收入状况满意度、护患关系满意度、从事肿瘤科护理工作年限、心理资本、年龄、参加院级以上培训次数、群众认可与尊重程度、夜班频次,建议医院和护理管理者应制定相应策略,减少肿瘤科护士工作倦怠。     

Measurement of chemiluminescence in freshly drawn human blood

Summary The aim of the present study was to investigate chemiluminescence (CL) of stimulated peripheral phagocytic cells (PC, i.e. granulocytes and monocytes) in patients with malignant disease at various stages. As a first step the zymosan-induced and luminol-amplified CL was determined in diluted whole blood samples from healthy volunteers. A characteristic daytime dependence of the CL activity was observed in six volunteers which had to be taken into account for blood sampling. The detectable CL was demonstrated to depend on the number of erythrocytes in the assay, but correction for this is not necessary for clinical investigation. The specific CL activity (activity related to 10³ PC, was significantly but identically increased both in 1) patients with acute inflammatory disease and 2) in patients with carcinoma. The total CL activity (activity/µl whole blood), however, was significantly increased in patients with acute inflammation as compared to the tumour group. This greatly reflects the leucocytosis of patients with acute inflammation. In a small number of patients with benign and malignant disease the CL of PC was measured both pre- and postoperatively. Operations in benign disease and palliative operations in malignancy did not influence the CL activity. In contrast, CL activity returned to normal after clinical cure by radical tumour resection.     

Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II)

Twenty-nine children (24, male; 5, female) with non-disseminated rhabdomyosarcomas of the bladder or prostate were treated (1978-1980) by a primary chemotherapy regimen consisting of vincristine, actinomycin D, and cyclophosphamide ("Pulse" VAC), with or without local radiotherapy. During the initial 20 wk of chemotherapy, nine children achieved a Clinical Complete Response (CCR). Three of these are without evidence of disease (NED) and have functional bladders, two following partial cystectomy. Four who achieved a CCR subsequently relapsed or remained biopsy positive, but are at present NED following radiotherapy and anterior exenteration. Two patients who achieved CCR status relapsed and have died of disease. Twelve patients had a Clinical Partial Response (CPR) in less than 20 wk and two others in less than 40 wk. Seven of these are NED with intact bladders following chemotherapy-radiotherapy; and an additional patient is NED following partial cystectomy. Four patients in the CPR group have been treated by exenteration following failure to achieve complete response, and are NED. One patient has died, and one has progressive disease. Six patients had an inadequate response to chemotherapy (NR). Anterior exenteration was carried out in three, and two of these have survived. The overall results in these 29 patients are: (A) alive and disease-free with functional bladders, 11; (B) alive and disease-free following anterior exenteration, 10; and (C) dead or death from tumor anticipated, 8. The function of retained bladders (11) has been satisfactory.     

Multicentre analysis of treatment planning information: Technical requirements,possible applications and a proposal

Digital data from 3‐D treatment planning computers is generally used for patient planning and then never considered again. However, such data contains enormous quantities of information regarding patient geometries, tissue outlining, treatment approaches and dose distributions. Were such data accessible from planning systems from multiple manufacturers, there would be substantial opportunities for undertaking quality assurance of radiotherapy clinical trials, prospective assessment of trial outcomes and basic treatment planning research and development. The technicalities of data exchange between planning systems are outlined, and previous attempts at producing systems capable of viewing and/or manipulating imaging and radiotherapy digital data reviewed. Development of a software system for enhancing the quality of Australasian clinical trials is proposed.     

Clinical Management Reporting and Objective Diagnostic Instruments for Spiritual Assessment in Spinal Cord Injury Patients

Objective Instruments (SPA/SSI) and Clinical Management Reports (CMRs) were used for diagnostic and follow-up spiritual assessment in a man with acute spinal cord injury (SCI) and for diagnostic measurement in 37 other SCI patients. A set of five characteristic spiritual concerns of SCI patients was identified. Further it was shown SCI patients require about five times as much time per patient as other hospital patients for both chaplaincy and social work providers. Recommendations to Chaplain SCI programs suggest the SPA/SSI and CMRs are extremely useful in more prompt and focused response to SCI patient need and better communication and support from other health professionals. Management should be sure sufficient chaplain staff are provided to SCI patients both in time alloted and in specialized diagnostic training, so the SCI cases will be processed most expeditously.     

The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV/AIDS with uridine triacetate

According to the NIH, about 275 000 patients receive treatment with 5-Fluorouracil (5-FU) and more than 1300 die from 5-FU toxicity every year from life-threatening myelosuppression, gastrointestinal complications, and neurotoxicity. Immunocompromised persons are at higher risk of developing toxicity. Recently uridine triacetate (Vistagard®) has been approved by the Food and Drug Administration (FDA) as the only specific antidote available for 5-FU poisoning. In a clinical trial (n = 135), 96% of patients with 5-FU toxicity recovered after treatment, where as in a historical control group only 10% survived. This is the first published case report of survival after 5-FU overdose who also was immunocompromised from HIV/AIDs. A 52 year old male with history of HIV/AIDS (CD4 70), CNS toxoplasmosis and anal cancer presented to the emergency department after realizing he had received an entire course of 5-FU in 24 instead of 96 h. Treatment with uridine triacetate was arranged in the emergency department. After receiving treatment the patient was asymptomatic and had an uncomplicated hospital course. 5-FU poisoning must be recognized early as uridine triacetate is approved by the FDA for use within 96 h following the end of 5-FU administration. Emergency medicine physicians should promptly recognize and treat 5-FU poisoning. However, this may be challenging as patients may not seek medical attention until many hours or several days after last administration since symptoms are often delayed with 5-FU poisoning.     

Are antioxidant enzymes essential markers in the diagnosis and monitoring of cancer patients – A review

Reactive oxygen species (ROS) play a significant role in human cells. Excessive ROS production damages important macromolecules such as nucleic acids and can initiate and develop the carcinogenesis process. Antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx), and xanthine oxidoreductase (XOR) are responsible for maintaining the balance between the functions of free radical formation and eliminating their excessive amounts.Based on the analyzed literature, the following conclusions can be made:1. Antioxidant enzymes activity are important for diagnosing neoplastic diseases such as non-small-cell lung cancer, bladder cancer, ovarian cancer, and colon cancer.2. Non-small-cell lung cancer is usually characterized by decreased SOD and CAT activity and increased glutathione GST activity. Lowered SOD, CAT, and GPx activity is characteristic of bladder cancer. XOR, CAT, SOD and GPx expression is decreased in patients with ovarian cancer. Colorectal cancer is characterized by increased MnSOD expression (in vitro studies) and SOD expression while CAT, GPx, and GR are decreased (in vivo study).3. SOD, CAT, and XOR are promising prognostic markers in cancer of the lung, bladder, ovarian, and colon.